Novel α-galactosidase a mutation in patients with severe cardiac manifestations of fabry disease

Giovanni Duro, M. Beatrice Musumeci, Paolo Colomba, Carmela Zizzo, Giuseppe Albeggiani, Vittoria Mastromarino, Massimo Volpe, Camillo Autore

Research output: Contribution to journalArticlepeer-review

Abstract

Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of α-galactosidase A (α-gal A), a lysosomal hydrolase. This inactivation is responsible for the accumulation of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. Fabry is considered a rare disease, with an incidence of 1:40,000; however, there are good reasons to believe that it is often seen but rarely diagnosed. To date, more than 600 mutations have been identified in human GLA gene that are responsible for FD. We describe the case of a 54-year-old male patient, who presented with left ventricular hypertrophy, chronic renal failure and acroparaesthesias, which are considered to be specific features of FD. Clinical and instrumental investigations showed several cardiovascular manifestations. The molecular analysis of GLA gene revealed a novel mutation in the fifth exon, called N249K, and the enzymatic analysis showed no α-galactosidase A activity. Family screening detected the same mutation in some relatives and also the enzymatic analysis confirmed the diagnosis of FD.In conclusion, these data suggest that the N249K mutation may be associated with cardiac manifestations of FD combined with other classical features of the disease.

Original languageEnglish
Pages (from-to)365-369
Number of pages5
JournalGene
Volume535
Issue number2
DOIs
Publication statusPublished - Feb 10 2014

Keywords

  • α-Galactosidase A
  • Fabry disease
  • High resolution melting
  • Hypertrophic cardiomyopathy
  • Mutation N249K

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'Novel α-galactosidase a mutation in patients with severe cardiac manifestations of fabry disease'. Together they form a unique fingerprint.

Cite this